Product Image

Omega 3 Mood

Country Life
4.8
★ ★ ★ ★ ★
(600 ratings)
EPA (Eicosapentaenoic Acid) 1000 mg
Fish Oil 2000 mg
Vitamin E 20 IU
DHA 150 mg
Product Image
Score79
Best suited to heart health, with the clearest benefits coming from the disclosed active ingredients. Natural vitamin E helps protect the oil, but molecular form, fish source, and independent purity evidence are missing.
How scoring works
Quantity:180 Softgel(s) • (90 servings)
Goals:
Heart Health
Cardiovascular Support
Anti-Inflammatory Support
Mental Focus

Score 79

Best suited to heart health, with the clearest benefits coming from the disclosed active ingredients. Natural vitamin E helps protect the oil, but molecular form, fish source, and independent purity evidence are missing.
How scoring works

Also available as

1 option
90 servings • Natural Lemon E 20 IU, DHA 150 mg +2 more • 90 Softgel(s) • 45 servings $34.71 ($0.77 per serving)
$62.71($0.69 per serving)
iHerb
$ 62.71
Walmart
$ 65.85
Pure Formulas
$ 62.71
Vitacost
$ 62.71
Report prices

Analysis

The EPA-heavy fish oil provides a substantial active serving for gradual mood, cardiovascular, and inflammatory support. Natural vitamin E helps protect the oil, but molecular form, fish source, and independent purity evidence are missing.

The high EPA amount and additional DHA directly support lipid management and cardiovascular inflammatory balance. The clearly disclosed fatty acids provide a meaningful heart-focused serving. The EPA-led ratio is coherent, but the molecular form and independent purity testing are not disclosed.

The EPA-heavy fish oil may support mood and reduce brain fog related to inflammatory imbalance. It is more suited to gradual background support than acute concentration. A substantial EPA amount gives the formula clear depth, while DHA is present only as a smaller companion.

Who is it for
  • People seeking heart health support
  • People seeking cardiovascular support support
  • People seeking anti-inflammatory support support
Best for
  • Heart Health
  • Cardiovascular Support
  • Anti-Inflammatory Support

Pros

  • The EPA-heavy fish oil provides a substantial active serving for gradual mood, cardiovascular, and inflammatory support.
  • The high EPA amount and additional DHA directly support lipid management and cardiovascular inflammatory balance.
  • The clearly disclosed fatty acids provide a meaningful heart-focused serving.
  • Fish oil may increase bleeding tendency when combined with anticoagulant or antiplatelet drugs.
  • The EPA-forward fish oil supplies a substantial combined EPA and DHA amount for lipid and inflammatory support.

Cons

  • Natural vitamin E helps protect the oil, but molecular form, fish source, and independent purity evidence are missing.
  • The EPA-led ratio is coherent, but the molecular form and independent purity testing are not disclosed.
  • Molecular form, fish species, purification, and independent testing are not disclosed, which limits quality confidence.
  • Natural vitamin E also protects the oil, although its own amount is too small for major antioxidant support.
  • Missing molecular-form, purification, source, and independent-testing details weaken the quality picture.

Warnings

  • Fish oil may increase bleeding tendency when combined with anticoagulant or antiplatelet drugs.

Nutrient quality

85 Highest impact

The high EPA amount gives the formula meaningful depth for its intended uses. Missing molecular-form and source details limit quality assurance despite the focused design.

Ingredient transparency

78 High impact

Fish oil, EPA, DHA, and vitamin E have stated amounts. Daily directions and complete excipient details are not supplied.

Customer satisfaction

71 High impact

The supplied aggregate satisfaction metric is strong and supported by the available feedback volume. No feedback excerpts or complaint themes are supplied, so specific experience patterns cannot be verified.

Value for money

81 Highest impact

Serving value appears reasonable but not exceptional. The focused ingredient profile avoids costly low-value extras.

Report analysis

Goals

Heart Health
Heart Health
Impact
Highest effect
A+ Goal FitA- Strength of SupportB- CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 1000 mg

The high EPA amount and additional DHA directly support lipid management and cardiovascular inflammatory balance. The clearly disclosed fatty acids provide a meaningful heart-focused serving.

The EPA-led ratio is coherent, but the molecular form and independent purity testing are not disclosed. Fish oil may increase bleeding tendency when combined with anticoagulant or antiplatelet drugs.

Study evidence
Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
A Goal FitB+ Strength of SupportB- CoverageA Formula Quality
Fish Oil · 2000 mgVitamin E · 20 IU

The EPA-forward fish oil supplies a substantial combined EPA and DHA amount for lipid and inflammatory support. Separate active amounts make the cardiovascular contribution easy to judge.

Natural vitamin E helps protect the oil from oxidation and fits the formula's purpose. Molecular form, fish species, purification, and independent testing are not disclosed, which limits quality confidence.

Study evidence
Fish Oil Supportive 185 studies
Vitamin E Mixed 79 studies
Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
Highest effect
A Goal FitB- Strength of SupportB- CoverageA Formula Quality
Fish Oil · 2000 mgVitamin E · 20 IU

A substantial EPA-led omega-3 serving directly supports production of inflammation-resolving mediators. Natural vitamin E also protects the oil, although its own amount is too small for major antioxidant support.

The active omega-3 dose is well disclosed and reaches a meaningful daily range. Missing molecular-form, purification, source, and independent-testing details weaken the quality picture.

Study evidence
Fish Oil Supportive 68 studies
Vitamin E Supportive 20 studies
Mental Focus
Mental Focus
Impact
High effect
C Goal FitA Strength of SupportC CoverageA Formula Quality

The EPA-heavy fish oil may support mood and reduce brain fog related to inflammatory imbalance. It is more suited to gradual background support than acute concentration.

A substantial EPA amount gives the formula clear depth, while DHA is present only as a smaller companion. Vitamin E supports the oil without adding an unrelated focus claim.

Study evidence

Ingredients

IngredientAmount per serving
Calories
20 {Calories}
Calories from Fat
20 {Calories}
Total Fat
2 Gram(s)
Saturated Fat
0 Gram(s)
Monounsaturated Fat
0.5 Gram(s)
Polyunsaturated Fat
1.5 Gram(s)
Eicosapentaenoic Acid
1000 mg
Docosahexaenoic Acid
150 mg
Cholesterol
20 mg
Protein
0.5 Gram(s)
Vitamin E
20 IU
Fish Oil concentrate
2000 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
EPA (Eicosapentaenoic Acid) · 1000 mg OverallScore71
C- Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyB+ Value

A high EPA dose and strongly EPA-led ratio fit heart and mood support goals well. The molecular form and independent purity testing are not disclosed, and vitamin E is the only listed oxidation protection. Cost per gram of EPA remains fair despite a higher serving cost.

View ingredientView products
Fish Oil · 2000 mg OverallScore51
F Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyB+ Value

The 1,150 mg combined EPA and DHA dose provides a useful active amount with transparent labeling. Vitamin E supports stability, but the oil's molecular form, source species, purification, and independent testing are not disclosed. Cost efficiency is favorable for the active amount supplied.

View ingredientView products
Vitamin E · 20 IU OverallScore50
D Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyB- Value

Natural d-alpha vitamin E offers better biological activity than a synthetic form, but the formula lacks broader vitamin E isomers. The amount is below the usual adult maintenance range. Cost is moderate for the natural form supplied.

View ingredientView products
Loading alternative details
78 Performance

Omega 3 Platinum+D

Zahler
<p>The ingredient profile is well aligned with the original’s omega-3 and vitamin focus, supplying 900 mg of EPA, 600 mg of DHA, 3000 mg of fish oil and 15 IU of vitamin E. Its combined EPA and DHA or total omega-3 amount matches or exceeds the original’s, giving it a strong core fatty-acid profile.</p>
75 Performance

Mega EPA/DHA

Life Extension
<p>The ingredient profile is well aligned with the original’s omega-3 and vitamin focus, supplying 720 mg of EPA, 480 mg of DHA, 2000 mg of fish oil and 2.7 mcg of vitamin E. Its combined EPA and DHA or total omega-3 amount matches or exceeds the original’s, giving it a strong core fatty-acid profile.</p>
73 Performance

Extreme Omega 2400 mg Lemon Natural Flavor

Natrol
<p>The ingredient profile is well aligned with the original’s omega-3 and vitamin focus, supplying 646 mg of EPA, 430 mg of DHA, 2400 mg of fish oil and 20.1 mg of vitamin E. EPA and DHA are each quantified, though their combined amount is lower than the original’s.</p>
76 Budget

Omega-3 Fish Oil 1000 mg Lemon

Natrol
<p>A lower cost per serving makes this a practical budget alternative, while it supplies 180 mg of EPA, 120 mg of DHA and 1000 mg of fish oil. Its combined EPA and DHA or total omega-3 amount is lower than the original’s, so the trade-off is a lighter omega-3 serving. Unlike the original, it does not disclose vitamin e.</p>
79 Budget

Omega-3 Fish Oil with Vitamin D 1000 mg Lemon Flavored

Swanson
<p>A lower cost per serving makes this a practical budget alternative, while it supplies 180 mg of EPA, 120 mg of DHA and 1000 mg of fish oil. Its combined EPA and DHA or total omega-3 amount is lower than the original’s, so the trade-off is a lighter omega-3 serving. Unlike the original, it does not disclose vitamin e.</p>
78 Budget

CoQ10 60 mg With Omega-3 Fish Oil

NOW
<p>A lower cost per serving makes this a practical budget alternative, while it supplies 40 mg of EPA, 25 mg of DHA, 250 mg of fish oil and 10 IU of vitamin E. Its combined EPA and DHA or total omega-3 amount is lower than the original’s, so the trade-off is a lighter omega-3 serving.</p>
80 Value

Alaska Wild Fish Oil Mega Omega-3

21st Century
<p>Strong serving value is paired with 965 mg of EPA, 385 mg of DHA and 1950 mg of fish oil. It matches or exceeds the original’s disclosed omega-3 amount and keeps both EPA and DHA clearly quantified, balancing cost-effectiveness with a useful ingredient profile. Unlike the original, it does not disclose vitamin e.</p>
81 Value

Omega-3

Solgar
<p>Strong serving value is paired with 1008 mg of EPA, 756 mg of DHA and 2800 mg of fish oil. It matches or exceeds the original’s disclosed omega-3 amount and keeps both EPA and DHA clearly quantified, balancing cost-effectiveness with a useful ingredient profile. Unlike the original, it does not disclose vitamin e.</p>
78 Value

Super Omega-3

Life Extension
<p>Strong serving value is paired with 700 mg of EPA and 500 mg of DHA. It matches or exceeds the original’s disclosed omega-3 amount and keeps both EPA and DHA clearly quantified, balancing cost-effectiveness with a useful ingredient profile. Unlike the original, it does not disclose vitamin e.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.
    Manson JE; Bassuk SS; Cook NR; Lee IM; Mora S; Albert CM; Buring JE; VITAL Research Group · Circulation research · 2020
    Randomized trial25,871 participantsCardiovascular Support forFish Oil
  2. Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.
    Doshi R; Kumar A; Thakkar S; Shariff M; Adalja D; Doshi A; Taha M; Gupta R; Desai R; Shah J; Gullapalli N · The American journal of cardiology · 2020
    Meta-analysis27,415 participants5 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  3. Effect of fish oil supplement in maintenance hemodialysis patients: a systematic review and meta-analysis of published randomized controlled trials.
    He L; Li MS; Lin M; Zhao TY; Gao P · European journal of clinical pharmacology · 2016
    Meta-analysis916 participants13 studies pooledAnti-Inflammatory Support forFish Oil
  4. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  5. Marine n-3 fatty acid treatment for carotid plaques in patients with type 2 diabetes.
    Zhuang P; Liu X; Jia W; Zheng W; Wan X; Chen W; Gu J; Li Y; Lan X; Li H; Tong W; Wu Y; Wu X; Ao Y; Ye H; Wu F; Zhu L; Zhang L; Li Y; Meng D; Tian Y; Wang A; Wu S; Zhu F; Zhang Y; Shi H; Yu X; Zhang F; Zhang Y; Jiao J · Cardiovascular diabetology · 2026
    Randomized trial415 participantsCardiovascular Support forFish Oil
  6. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
    Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W · European journal of clinical nutrition · 2019
    Meta-analysis3,000 participants51 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  7. No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals.
    Pot GK; Brouwer IA; Enneman A; Rijkers GT; Kampman E; Geelen A · European journal of clinical nutrition · 2010
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  8. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  9. Long-Chain Polyunsaturated Fatty Acids Are Associated with Blood Pressure and Hypertension over 10-Years in Black South African Adults Undergoing Nutritional Transition.
    Zec MM; Schutte AE; Ricci C; Baumgartner J; Kruger IM; Smuts CM · Foods (Basel, Switzerland) · 2020
    Cohort study300 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  10. Fish oil, enriched with polyunsaturated fatty acids of the omega-3-type accelerates the nucleation time in healthy subjects.
    Janowitz P; Swobodnik W; Wechsler JG; Janowitz A; Saal D; Ditschuneit H · Klinische Wochenschrift · 1991
    Non-randomized trial24 participantsCardiovascular Support forFish Oil
  11. Effects of fish oil supplementation on biomarkers of vascular endothelial function in middle-aged and older adults: a randomized controlled trial.
    Quan C; Tang W; Qin Y; Nian Z; Li Z; Mao L · Food & function · 2026
    Randomized trial240 participantsAnti-Inflammatory Support forFish Oil
  12. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  13. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  14. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  15. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  16. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  17. The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review.
    Innes JK; Calder PC · International journal of molecular sciences · 2018
    Systematic review527 participants6 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  18. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  19. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  20. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  21. Efficacy of fish oil and its components in the management of psoriasis: a systematic review of 18 randomized controlled trials.
    Chen X; Hong S; Sun X; Xu W; Li H; Ma T; Zheng Q; Zhao H; Zhou Y; Qiang Y; Li B; Li X · Nutrition reviews · 2021
    Meta-analysis927 participants18 studies pooledAnti-Inflammatory Support forFish Oil
  22. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  23. Associations of habitual fish oil supplementation with cardiovascular outcomes and all cause mortality: evidence from a large population based cohort study.
    Li ZH; Zhong WF; Liu S; Kraus VB; Zhang YJ; Gao X; Lv YB; Shen D; Zhang XR; Zhang PD; Huang QM; Chen Q; Wu XB; Shi XM; Wang D; Mao C · BMJ (Clinical research ed.) · 2020
    Cohort study427,678 participantsCardiovascular Support forFish Oil
  24. The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients.
    Deike E; Bowden RG; Moreillon JJ; Griggs JO; Wilson RL; Cooke M; Shelmadine BD; Beaujean AA · Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2013
    Randomized trial31 participantsAnti-Inflammatory Support forFish Oil
  25. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
    Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A · The American journal of clinical nutrition · 1997
    Randomized trial234 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  26. Regular use of fish oil supplements and course of cardiovascular diseases: prospective cohort study.
    Chen G; Qian ZM; Zhang J; Zhang S; Zhang Z; Vaughn MG; Aaron HE; Wang C; Lip GY; Lin H · BMJ medicine · 2024
    Cohort study415,737 participantsCardiovascular Support forFish Oil
  27. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  28. Eicosapentaenoic Acid combined with optimal statin therapy improves endothelial dysfunction in patients with coronary artery disease.
    Toyama K; Nishioka T; Isshiki A; Ando T; Inoue Y; Kirimura M; Kamiyama T; Sasaki O; Ito H; Maruyama Y; Yoshimoto N · Cardiovascular drugs and therapy · 2014
    Randomized trial80 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  29. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  30. A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer.
    Mocellin MC; Camargo CQ; Nunes EA; Fiates GMR; Trindade EBSM · Clinical nutrition (Edinburgh, Scotland) · 2017
    Meta-analysis475 participants9 studies pooledAnti-Inflammatory Support forFish Oil
  31. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome.
    Satoh N; Shimatsu A; Kotani K; Himeno A; Majima T; Yamada K; Suganami T; Ogawa Y · Hypertension research : official journal of the Japanese Society of Hypertension · 2010
    Randomized trial92 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  32. Cardiovascular Benefits of Fish-Oil Supplementation Against Fine Particulate Air Pollution in China.
    Lin Z; Chen R; Jiang Y; Xia Y; Niu Y; Wang C; Liu C; Chen C; Ge Y; Wang W; Yin G; Cai J; Clement V; Xu X; Chen B; Chen H; Kan H · Journal of the American College of Cardiology · 2020
    Randomized trial65 participantsCardiovascular Support forFish Oil
  33. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  34. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  35. Effects of delta-tocotrienol supplementation on Glycemic Control, oxidative stress, inflammatory biomarkers and miRNA expression in type 2 diabetes mellitus: A randomized control trial.
    Mahjabeen W; Khan DA; Mirza SA; Pervez MA · Phytotherapy research : PTR · 2021
    Randomized trial110 participantsAnti-Inflammatory Support forVitamin E
  36. Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials.
    Saboori S; Shab-Bidar S; Speakman JR; Yousefi Rad E; Djafarian K · European journal of clinical nutrition · 2016
    Meta-analysis495 participants12 studies pooledAnti-Inflammatory Support forVitamin E
  37. Efficacy of Nutritional Interventions on Inflammatory Markers in Haemodialysis Patients: A Systematic Review and Limited Meta-Analysis.
    Khor BH; Narayanan SS; Sahathevan S; Gafor AHA; Daud ZAM; Khosla P; Sabatino A; Fiaccadori E; Chinna K; Karupaiah T · Nutrients · 2018
    Meta-analysis46 studies pooledAnti-Inflammatory Support forVitamin E
  38. Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis.
    Chee NM; Sinnanaidu RP; Chan WK · Journal of gastroenterology and hepatology · 2024
    Meta-analysis8 studies pooledAnti-Inflammatory Support forVitamin E
  39. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial.
    Pervez MA; Khan DA; Slehria AUR; Ijaz A · Complementary therapies in medicine · 2021
    Randomized trial71 participantsAnti-Inflammatory Support forVitamin E
  40. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  41. Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
    Loffredo L; Perri L; Di Castelnuovo A; Iacoviello L; De Gaetano G; Violi F · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2016
    Meta-analysis16 studies pooledCardiovascular Support forVitamin E
  42. Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.
    Chen B; Li Y; Li Z; Hu X; Zhen H; Chen H; Nie C; Hou Y; Zhu S; Xiao L; Li T · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2025
    Randomized trial90 participantsCardiovascular Support forVitamin E
  43. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
    Lonn E; Bosch J; Yusuf S; Sheridan P; Pogue J; Arnold JM; Ross C; Arnold A; Sleight P; Probstfield J; Dagenais GR; HOPE and HOPE-TOO Trial Investigators · JAMA · 2005
    Randomized trial9,541 participantsCardiovascular Support forVitamin E
  44. Independent and combined associations of dietary antioxidant exposure with all-cause and cause-specific mortality in the general population.
    Liu Z; He Z; Xing Y · Journal of nutritional science · 2026
    Cohort study34,955 participantsCardiovascular Support forVitamin E
  45. Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study.
    Chin SF; Ibahim J; Makpol S; Abdul Hamid NA; Abdul Latiff A; Zakaria Z; Mazlan M; Mohd Yusof YA; Abdul Karim A; Wan Ngah WZ · Nutrition & metabolism · 2011
    Randomized trial62 participantsCardiovascular Support forVitamin E
  46. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  47. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  48. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)